📈 Jumpstart Signal Watchlist — October 08, 2026

🏢 What they do: OneSpan provides cybersecurity and digital agreement solutions, including identity verification, authentication, fraud prevention, and mobile app security. Its digital agreement products support secure e-signatures, online notarization, and automated document workflows.
- 🎯 Current $18.01 is 11% below 3yr high $20.23 · ⏳ SMA200 $13.54 (current price $18.01 is above) · 💰 Market Cap $662M
- OSPN shows decent technicals supported by positive sentiment.

💎 Quality (Q): 39/60
- 🏦 Low drawdown (14.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; ROE 25% (>15%); Low LT D/E 0.00 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×1).
✅ OneSpan Expands OneSpan Sign Beyond eSignature Capabilities to Move Customer-Facing Agreements Forward, Faster and With Greater Confidence — Business Wire.
🤖 OneSpan announced an expansion of its Digital Agreements portfolio with capabilities intended to support agreement workflows beyond e-signatures, including document preparation, identity verification, and workflow integrations. The product expansion could strengthen the platform’s value to customers and support growth.
🍭 Bonus (B): 10/10 — Computer Integrated Systems Design (Technology sector)

🏢 What they do: Red Violet, Inc. provides identity intelligence software and data solutions for identity verification, fraud detection and prevention, risk mitigation, investigations, due diligence, customer acquisition, and asset recovery. Its products include idiCORE and FOREWARN.
- 🎯 Current $79.86 is 0% below 3yr high $80.25 · ⏳ SMA200 $55.21 (current price $79.86 is above) · 💰 Market Cap $1.1B
- RDVT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (13.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 89% (>20%); Revenue growth 23% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 60 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ Red Violet (NASDAQ:RDVT) Upgraded at Zacks Research — MarketBeat.
🤖 Zacks Research upgraded Red Violet from Hold to Strong Buy. The article also notes the company beat quarterly EPS estimates, though it mentions mixed rating changes from other analysts.
✅ Red Violet (RDVT) Expands FOREWARN Reach Through ... — Yahoo Finance.
🤖 FOREWARN partnered with the Pacific West Association of REALTORS to make its identity-verification and safety solutions available to more than 10,000 members. The expanded reach could support adoption of Red Violet’s services.
✅ Red Violet (NASDAQ:RDVT) Sets New 12-Month High — MarketBeat.
🤖 Red Violet shares reached a new 52-week high, reflecting strong recent share performance. The article also cites a broadly positive analyst consensus, alongside a downgrade from Weiss Ratings.
🍭 Bonus (B): 10/10 — Prepackaged Software (Technology sector)

🏢 What they do: Magnite is an advertising technology company that provides a sell-side platform for digital advertising. Its software helps publishers and media owners manage and monetize ad inventory across channels like connected TV, video, mobile, and desktop, while also connecting them with advertisers and agencies.
- 🎯 Current $25.45 is 4% below 3yr high $26.52 · ⏳ SMA200 $17.10 (current price $25.45 is above) · 💰 Market Cap $3.6B
- MGNI shows decent technicals supported by positive sentiment.

💎 Quality (Q): 50/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 62% (>20%); ROE 18% (>15%); Low LT D/E 0.37 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 2/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ Magnite Successfully Completes Term Loan and Revolving Credit Facility Repricing — GlobeNewswire.
🤖 Magnite reduced the interest margins on its term loan and revolving credit facility. The term-loan repricing is expected to save approximately $1.8 million in annualized cash interest, lowering financing costs.
✅ Magnite (MGNI) Lands HP TV+ Deal But Is The Upside Already Priced In — Yahoo Finance.
🤖 Magnite was selected as the primary video ad server and programmatic technology provider for HP TV+, adding a new streaming-platform relationship. The article also notes the stock’s recent gains and raises the question of whether the deal’s potential is already reflected in the share price.
⚪️ Magnite Sees Unusually High Options Volume (NASDAQ: MGNI) — MarketBeat.
🤖 The article reports unusually high options volume and summarizes analyst ratings and price targets, but does not identify a new company-specific catalyst or a fresh rating change within the article. The options activity alone does not establish a directional outlook.
🍭 Bonus (B): 10/10 — Computer Programming & Data Processing (Technology sector)

🏢 What they do: Exelixis is an oncology-focused biotechnology company that discovers, develops, and commercializes medicines for hard-to-treat cancers. Its main products include CABOMETYX (cabozantinib), COMETRIQ (cabozantinib), and COTELLIC (cobimetinib), and it also advances a pipeline of small molecules and biotherapeutics for cancer treatment.
- 🎯 Current $59.02 is 0% below 3yr high $59.13 · ⏳ SMA200 $49.25 (current price $59.02 is above) · 💰 Market Cap $14.7B
- EXEL shows favorable technicals but negative sentiment warrants caution.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (11.8% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 26% (>20%); ROE 47% (>15%); Low LT D/E 0.00 (<1.0).
📢 Sentiment (S): 3/10
- 🗞️ News sentiment is negative (mixed coverage; ✅×1 ❌×3 ⚪️×1; showing 4 of 5).
✅ Exelixis Shares Rising on CABOMETYX Revenue — Yahoo Finance.
🤖 The article highlights CABOMETYX revenue growth of 10% year over year and Exelixis’ substantial cash position and share repurchases. Those commercial and capital-return details are supportive for the stock.
❌ Exelixis (NASDAQ:EXEL) Price Target Cut to $45.00 by Analysts at Royal Bank of Canada — MarketBeat.
🤖 Royal Bank of Canada lowered its price target from $46 to $45 while maintaining a sector perform rating. The modest target reduction is a negative analyst signal for EXEL.
❌ Could Zanzalintinib's FDA Delay Affect Exelixis' Growth? — Yahoo Finance.
🤖 The FDA extended its review of zanzalintinib for metastatic colorectal cancer by three months, moving the target action date to March 3, 2027. The delay postpones a potential regulatory decision and launch.
⚪️ Exelixis Eyes Oncology Deals, Readies Zanzalintinib — Yahoo Finance.
🤖 Management described plans to expand oncology franchises through internal development, selective business development, and potential collaborations, while noting the extended zanzalintinib review timeline. The strategic ambitions are balanced by the regulatory delay.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Five9, Inc. provides cloud contact center software, including its Intelligent CX platform for managing customer interactions across voice and digital channels like chat, email, SMS, and social media. Its products also include AI, automation, analytics, and workforce optimization tools that help businesses run customer service and sales operations.
- 🎯 Current $35.15 is 59% below 3yr high $85.47 · ⏳ SMA200 $22.85 (current price $35.15 is above) · 💰 Market Cap $2.6B
- FIVN shows decent technicals supported by positive sentiment.

💎 Quality (Q): 45/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 300% (>20%); Low LT D/E 0.25 (<1.0); PEG ratio 0.17 (<1.5).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 54 in healthy mid-range
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×4; showing 3 of 4).
✅ DA Davidson raises Five9 stock price target on revenue ... — Investing.com.
🤖 DA Davidson raised its price target to $33 from $28 while maintaining a Neutral rating, citing strong AI revenue growth. The article is dated September 28, 2026; its October 8 update does not change the original publication date.
✅ FBN Securities Upgrades Five9 (NASDAQ:FIVN) to "Strong-Buy" — MarketBeat.
🤖 FBN Securities upgraded Five9 to Strong Buy, adding to the favorable analyst outlook. The article was published September 17, 2026.
✅ Cantor Fitzgerald raises Five9 stock price target to $40 on valuation — Investing.com.
🤖 Cantor Fitzgerald raised its price target from $34 to $40 and maintained an Overweight rating. The article was published September 21, 2026.
🍭 Bonus (B): 10/10 — Computer Processing & Data Prep (Technology sector)

🏢 What they do: GigaCloud Technology Inc. (GCT) operates a B2B e-commerce marketplace specializing in large-parcel merchandise like furniture, appliances, and fitness equipment. It provides an end-to-end platform that connects manufacturers (primarily in Asia) with retailers in markets such as the US and Europe, handling product sourcing, logistics, global fulfillment across 39 facilities, sales, and delivery.
- 🎯 At/above 3yr high $56.42 (current $56.42) · ⏳ SMA200 $42.58 (current price $56.42 is above) · 💰 Market Cap $526M
- GCT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 Base breakout (range: 8.4%); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 27% (>20%); Revenue growth 28% (>15%); ROE 29% (>15%).
⏰ Entry (E): 5/20
- 🔔 Strong above EMA21 (6.0%)
- 🔔 Strong above EMA50 (12.1%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 66 showing strength
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive (mixed coverage; ✅×3 ❌×1 ⚪️×1; showing 4 of 5).
✅ GigaCloud Technology (NASDAQ:GCT) Hits New 12-Month High—Here's Why — MarketBeat.
🤖 The article reports GCT reached a new 12-month high and notes recent analyst rating upgrades, including Zacks Research raising its rating to strong buy. The price milestone and upgrades are positive signals, though the article does not establish that they predict future performance.
✅ GigaCloud Technology Inc stock reaches 52-week high at $56.37 — Investing.com.
🤖 GCT reached a 52-week high, and the article cites second-quarter revenue growth of 28%, earnings that exceeded expectations, and a newly approved $120 million buyback plan. These reported results and capital-return plans are positive company-specific developments.
❌ GigaCloud technology director Bernes sells $990k in shares — Investing.com.
🤖 Director Marshall Bernes sold approximately $990,000 of GCT shares in late September. Insider selling may weigh on sentiment, though the article also recaps the company’s strong second-quarter results and buyback plan.
⚪️ GigaCloud Technology (NASDAQ:GCT) Downgraded by Wall Street Zen to Buy — MarketBeat.
🤖 Wall Street Zen lowered its rating from strong buy to buy, while Weiss Ratings raised its rating from hold to buy. The mixed rating changes do not point clearly in one direction.
🍭 Bonus (B): 0/10 — Catalog & Mail-Order